Baxter International (NYSE:BAX) Issues Q1 2025 Earnings Guidance

Baxter International (NYSE:BAX) updated its first quarter 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.470-0.500 for the period, compared to the consensus estimate of 0.490. The company issued revenue guidance of $3.7 billion-$3.7 billion, compared to the consensus revenue estimate of $2.6 billion. Baxter International also updated its FY 2025 guidance to 2.450-2.550 EPS.

Wall Street Analysts Forecast Growth

BAX has been the topic of several recent analyst reports. Barclays initiated coverage on Baxter International in a research report on Thursday. They set an “overweight” rating and a $39.00 price target on the stock. StockNews.com cut shares of Baxter International from a “buy” rating to a “hold” rating in a research note on Monday, November 11th. Citigroup lowered their price objective on shares of Baxter International from $37.00 to $35.00 and set a “neutral” rating on the stock in a research note on Wednesday, December 11th. Stifel Nicolaus reduced their price target on Baxter International from $46.00 to $38.00 and set a “buy” rating for the company in a report on Monday, November 11th. Finally, JPMorgan Chase & Co. lowered their price target on Baxter International from $38.00 to $36.00 and set a “neutral” rating on the stock in a research report on Friday. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $38.80.

Baxter International Trading Up 1.3 %

Shares of NYSE:BAX opened at $33.87 on Friday. The stock has a market cap of $17.29 billion, a PE ratio of -26.46, a P/E/G ratio of 10.62 and a beta of 0.61. The company has a quick ratio of 1.09, a current ratio of 1.43 and a debt-to-equity ratio of 1.31. Baxter International has a 12-month low of $28.33 and a 12-month high of $44.01. The business has a 50 day moving average of $30.65 and a 200-day moving average of $34.14.

Baxter International (NYSE:BAX) last released its quarterly earnings results on Thursday, February 20th. The medical instruments supplier reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.06. The business had revenue of $2.75 billion during the quarter, compared to the consensus estimate of $2.67 billion. Baxter International had a positive return on equity of 16.67% and a negative net margin of 5.05%. As a group, equities research analysts forecast that Baxter International will post 2.48 earnings per share for the current year.

Baxter International Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Friday, February 28th will be issued a dividend of $0.17 per share. The ex-dividend date is Friday, February 28th. This represents a $0.68 annualized dividend and a dividend yield of 2.01%. Baxter International’s dividend payout ratio is presently -53.13%.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.